To address this question, we developed a rat model of Nf1-deficient breast cancer by creating several distinct germline Nf1 indels using CRISPR/Cas9 genome editing in immunocompetent Sprague Dawley rats (Dischinger et al., 2018). The gene discussed is NF1; the disease is breast carcinoma.